Anthony Boral
2016
In 2016, Anthony Boral earned a total compensation of $932.6K as Chief Medical Officer at Blueprint Medicines, a 20% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $146,016 |
|---|---|
| Option Awards | $402,184 |
| Salary | $376,442 |
| Other | $7,950 |
| Total | $932,592 |
Boral received $402.2K in option awards, accounting for 43% of the total pay in 2016.
Boral also received $146K in non-equity incentive plan, $376.4K in salary and $8K in other compensation.
Rankings
In 2016, Anthony Boral's compensation ranked 8,570th out of 14,075 executives tracked by ExecPay. In other words, Boral earned more than 39.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,570 out of 14,075 | 39th |
Division Manufacturing | 3,298 out of 5,489 | 40th |
Major group Chemicals And Allied Products | 1,111 out of 1,895 | 41st |
Industry group Drugs | 868 out of 1,538 | 44th |
Industry Pharmaceutical Preparations | 689 out of 1,176 | 41st |
Source: SEC filing on April 27, 2018.
Boral's colleagues
We found five more compensation records of executives who worked with Anthony Boral at Blueprint Medicines in 2016.
2016
Marion Dorsch
Blueprint Medicines
Chief Scientific Officer
2016
Jeffrey Albers
Blueprint Medicines
Chief Executive Officer
2016
Tracey McCain
Blueprint Medicines
Chief Legal Officer
2016
Kate Haviland
Blueprint Medicines
Chief Business Officer
2016
Michael Landsittel
Blueprint Medicines